Suscribirse

Fetal reduction of triplet pregnancies to twins vs singletons: a meta-analysis of survival and pregnancy outcome - 23/08/22

Doi : 10.1016/j.ajog.2022.03.050 
Kamran Hessami, MD a, Mark I. Evans, MD b, c, Ahmed A. Nassr, MD, PhD a, Jimmy Espinoza, MD a, Roopali V. Donepudi, MD a, Magdalena Sanz Cortes, MD, PhD a, Eyal Krispin, MD a, Shayan Mostafaei, PhD d, Michael A. Belfort, MD, PhD a, Alireza A. Shamshirsaz, MD a,
a Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Baylor College of Medicine and Texas Children’s Fetal Center, Texas Children’s Hospital Pavilion for Women, Houston, TX 
b Comprehensive Genetics, PLLC, New York, NY 
c Department of Obstetrics and Gynecology, Icahn School of Medicine at Mount Sinai, New York, NY 
d Division of Clinical Geriatrics, Department of Neurobiology, Care Sciences and Society, Karolinska Institute, Stockholm, Sweden 

Corresponding author: Alireza A. Shamshirsaz, MD.

Abstract

Objective

This systematic review and meta-analysis aimed to compare the fetal survival rate and perinatal outcomes of triplet pregnancies after selective reduction to twin pregnancies vs singleton pregnancies.

Data Sources

PubMed, Web of Science, Scopus, and Embase were systematically searched from the inception of the databases to January 16, 2022.

Study Eligibility Criteria

Studies comparing the survival and perinatal outcomes between reduction to twin pregnancies and reduction to singleton pregnancies were included. The primary outcomes were fetal survival, defined as a live birth at >24 weeks of gestation. The secondary outcomes were gestational age at birth, preterm birth at <32 and <34 weeks of gestation, early pregnancy loss (<24 weeks of gestation), low birthweight, and rate of neonatal demise (up to 28 days after birth).

Methods

The random-effect model was used to pool the mean differences or odds ratios and the corresponding 95% confidence intervals. To provide a range of expected effects if a new study was conducted, 95% prediction intervals were calculated for outcomes presented in >3 studies.

Results

Of note, 10 studies with 2543 triplet pregnancies undergoing fetal reduction, of which 2035 reduced to twin pregnancies and 508 reduced to singleton pregnancies, met the inclusion criteria. Reduction to twin pregnancies had a lower rate of fetal survival (odds ratio, 0.61; 95% confidence interval, 0.40–0.92; P=.02; 95% prediction interval, 0.36–1.03) and comparable rates of early pregnancy loss (odds ratio, 0.89; 95% confidence interval, 0.58–1.38; P=.61; 95% prediction interval, 0.54–1.48) and neonatal demise (odds ratio, 0.57; 95% confidence interval, 0.09–3.50; P=.55) than reduction to singleton pregnancies. Reduction to twin pregnancies had a significantly lower gestation age at birth (weeks) (mean difference, −2.20; 95% confidence interval, −2.80 to −1.61; P<.001; 95% prediction interval, −4.27 to −0.14) than reduction to singleton pregnancies. Furthermore, reduction to twin pregnancies was associated with lower birthweight and greater risk of preterm birth at <32 and <34 weeks of gestation.

Conclusion

Triplet pregnancies reduced to twin pregnancies had a lower fetal survival rate of all remaining fetuses, lower gestational age at birth, higher risk of preterm birth, and lower birthweight than triplet pregnancies reduced to singleton pregnancies; reduction to twin pregnancies vs reduction to singleton pregnancies showed no substantial difference for the rates of early pregnancy loss and neonatal death.

El texto completo de este artículo está disponible en PDF.

Key words : fetal reduction, meta-analysis, pregnancy outcome, triplet pregnancy, twin pregnancy


Esquema


 The authors report no conflict of interest.


© 2022  Elsevier Inc. Reservados todos los derechos.
Añadir a mi biblioteca Eliminar de mi biblioteca Imprimir
Exportación

    Exportación citas

  • Fichero

  • Contenido

Vol 227 - N° 3

P. 430 - septembre 2022 Regresar al número
Artículo precedente Artículo precedente
  • Long-term health outcomes of children born to mothers with hyperemesis gravidarum: a systematic review and meta-analysis
  • Kelly Nijsten, Larissa A.W. Jansen, Jacqueline Limpens, Martijn J.J. Finken, Marjette H. Koot, Iris J. Grooten, Tessa J. Roseboom, Rebecca C. Painter
| Artículo siguiente Artículo siguiente
  • Does vaginal progesterone prevent recurrent preterm birth in women with a singleton gestation and a history of spontaneous preterm birth? Evidence from a systematic review and meta-analysis
  • Agustin Conde-Agudelo, Roberto Romero

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.

¿Ya suscrito a @@106933@@ revista ?

@@150455@@ Voir plus

Mi cuenta


Declaración CNIL

EM-CONSULTE.COM se declara a la CNIL, la declaración N º 1286925.

En virtud de la Ley N º 78-17 del 6 de enero de 1978, relativa a las computadoras, archivos y libertades, usted tiene el derecho de oposición (art.26 de la ley), el acceso (art.34 a 38 Ley), y correcta (artículo 36 de la ley) los datos que le conciernen. Por lo tanto, usted puede pedir que se corrija, complementado, clarificado, actualizado o suprimido información sobre usted que son inexactos, incompletos, engañosos, obsoletos o cuya recogida o de conservación o uso está prohibido.
La información personal sobre los visitantes de nuestro sitio, incluyendo su identidad, son confidenciales.
El jefe del sitio en el honor se compromete a respetar la confidencialidad de los requisitos legales aplicables en Francia y no de revelar dicha información a terceros.


Todo el contenido en este sitio: Copyright © 2026 Elsevier, sus licenciantes y colaboradores. Se reservan todos los derechos, incluidos los de minería de texto y datos, entrenamiento de IA y tecnologías similares. Para todo el contenido de acceso abierto, se aplican los términos de licencia de Creative Commons.